BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23165465)

  • 21. Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.
    Pastick KA; Nalintya E; Tugume L; Ssebambulidde K; Stephens N; Evans EE; Ndyetukira JF; Nuwagira E; Skipper C; Muzoora C; Meya DB; Rhein J; Boulware DR; Rajasingham R
    Med Mycol; 2020 Apr; 58(3):282-292. PubMed ID: 31689712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis
    Munzen ME; Reguera Gomez M; Hamed MF; Enriquez V; Charles-Niño CL; Dores MR; Alviña K; Martinez LR
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0045923. PubMed ID: 37750714
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 24. Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.
    de Carvalho Santana R; Schiave LA; Dos Santos Quaglio AS; de Gaitani CM; Martinez R
    Mycopathologia; 2017 Oct; 182(9-10):855-861. PubMed ID: 28656554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.
    O'Connor L; Livermore J; Sharp AD; Goodwin J; Gregson L; Howard SJ; Felton TW; Schwartz JA; Neely MN; Harrison TS; Perfect JR; Hope WW
    J Infect Dis; 2013 Jul; 208(2):351-61. PubMed ID: 23599314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluconazole monotherapy for cryptococcosis in non-AIDS patients.
    Yamaguchi H; Ikemoto H; Watanabe K; Ito A; Hara K; Kohno S
    Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):787-92. PubMed ID: 8950555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
    Hope W; Stone NRH; Johnson A; McEntee L; Farrington N; Santoro-Castelazo A; Liu X; Lucaci A; Hughes M; Oliver JD; Giamberardino C; Mfinanga S; Harrison TS; Perfect JR; Bicanic T
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
    Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
    Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
    Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.
    Livermore J; Howard SJ; Sharp AD; Goodwin J; Gregson L; Felton T; Schwartz JA; Walker C; Moser B; Müller W; Harrison TS; Perfect JR; Hope WW
    mBio; 2014 Jan; 5(1):e00725-13. PubMed ID: 24473125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
    Larsen RA; Bauer M; Thomas AM; Graybill JR
    Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
    Silva EG; Paula CR; de Assis Baroni F; Gambale W
    Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS.
    Rodero L; Córdoba S; Cahn P; Soria M; Lucarini M; Davel G; Kaufman S; Canteros C; Guelfand L
    Med Mycol; 2000 Jun; 38(3):201-7. PubMed ID: 10892987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis.
    Garvey EP; Sharp AD; Warn PA; Yates CM; Schotzinger RJ
    J Antimicrob Chemother; 2018 Oct; 73(10):2815-2822. PubMed ID: 29947783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system.
    Khan AA; Alanazi AM; Jabeen M; Khan S; Malik A
    Eur J Pharm Sci; 2018 Jul; 119():171-178. PubMed ID: 29653177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptococcal liver abscess: a case report of successful treatment with amphotericin-B and literature review.
    Liu PY; Yang Y; Shi ZY
    Jpn J Infect Dis; 2009 Jan; 62(1):59-60. PubMed ID: 19168962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptococcal meningoencephalitis: time for action.
    Stott KE; Loyse A; Jarvis JN; Alufandika M; Harrison TS; Mwandumba HC; Day JN; Lalloo DG; Bicanic T; Perfect JR; Hope W
    Lancet Infect Dis; 2021 Sep; 21(9):e259-e271. PubMed ID: 33872594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
    Shoji H; Takuma T; Ohbayashi H; Yoshida K; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Oct; 18(5):775-9. PubMed ID: 22318291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar.
    Warrell CE; Macrae C; McLean ARD; Wilkins E; Ashley EA; Smithuis F; Tun NN
    BMC Infect Dis; 2021 Apr; 21(1):375. PubMed ID: 33882845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.